Skip to main content
. 2018 Sep;11(9):1301–1310. doi: 10.1016/j.jcmg.2018.06.021

Table 2.

Patient Outcomes by Guideline Risk Levels

ACC (2012)
ESC (2013)
NICE (2016)
Low Risk High Risk Low Risk High Risk Low Risk High Risk
PROMISE
 Patients 250 9,753 251 9,752 1,002 9,001
 CAD on CCTA 108 4,433 108 4,433 456 4,085
 Normal 55 (50.9) 1,463 (33.0) 55 (50.9) 1,463 (33.0) 155 (34.0) 1,363 (33.4)
 Mild CAD 50 (46.3) 2,436 (55.0) 50 (46.3) 2,436 (55.0) 262 (57.5) 2,224 (54.4)
 Obstructive CAD 3 (2.8) 534 (12.0) 3 (2.8) 534 (12.0) 39 (8.6) 498 (12.2)
 Prognostically significant CAD 0 (0) 144 (3.2) 0 (0) 144 (3.2) 11 (2.4) 133 (3.3)
 Subsequent coronary revascularization—90 days 3 (1.2) 468 (4.8) 3 (1.2) 468 (4.8) 23 (2.3) 448 (5.0)
 PCI 3 (1.2) 361 (3.7) 3 (1.2) 361 (3.7) 22 (2.2) 342 (3.8)
 CABG 0 (0.0) 107 (1.1) 0 (0.0) 107 (1.1) 1 (0.1) 106 (1.2)
 CVD death or nonfatal MI—1 yr 2 (0.8) 155 (1.6) 2 (0.8) 155 (1.6) 9 (0.9) 148 (1.6)
SCOT-HEART
 Patients 528 3,242 748 3,022 1,447 2,323
 CAD on CCTA 193 1,426 305 1,314 591 1,028
 Normal 138 (71.5) 498 (34.9) 198 (64.9) 438 (33.3) 296 (50.1) 340 (33.1)
 Mild CAD 46 (23.8) 578 (40.5) 92 (30.2) 532 (40.5) 239 (40.4) 385 (37.5)
 Obstructive CAD 9 (4.7) 350 (24.5) 15 (4.9) 344 (26.2) 56 (9.5) 303 (29.5)
 Prognostically significant CAD 4 (2.1) 127 (8.9) 6 (2.0) 125 (9.5) 12 (2.0) 119 (11.6)
 Subsequent coronary revascularization—90 days 2 (0.4) 249 (7.7) 4 (0.5) 247 (8.2) 7 (0.5) 244 (10.5)
 PCI 2 (0.4) 217 (6.7) 4 (0.5) 215 (7.1) 7 (0.5) 212 (9.1)
 CABG 0 (0.0) 33 (1.0) 0 (0.0) 33 (1.1) 0 (0.0) 33 (1.4)
 CVD death or nonfatal MI—3 yrs 2 (0.4) 71 (2.2) 4 (0.5) 69 (2.3) 17 (1.2) 56 (2.4)

Values are n or n (%).

CABG = coronary artery bypass graft; CAD = coronary artery disease; CCTA = coronary computed tomography angiography; MI = myocardial infarction; PCI = percutaneous coronary intervention; other abbreviations as in Table 1.

Prognostically significant CAD was defined as 3-vessel disease, 2-vessel disease including the proximal left anterior descending artery, or obstructive disease involving the left main stem.